We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

ORTEXORTEX News
Tracking TVRD? Get live short interest, options flow, and signals on ORTEX.Sign up free →
TV

Tvardi Therapeutics, Inc. (TVRD) short interest & options flow

NASDAQ

Tvardi Therapeutics heads into its May 14 earnings print with analysts turning more negative and short sellers trimming — a setup that tells two different stories about where the stock goes from here. The clearest recent signal came from the Street. Barclays downgraded TVRD to Underweight on April 20, cutting its target from $4 to $3 — below the current price of $3.14. The same…

$1.34-4.96% 1d+55.56% 1w+30.10% 1mClose: 11 Nov 2026
Short interest % of float
Dropping
Live SI on ORTEX →
Availability
Low and dropping
Live availability on ORTEX →
Market cap
$18M
Next earnings
13 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 12 Nov 2026

ORTEX chart of Tvardi Therapeutics, Inc. (TVRD) share price and short interest (% of free float), six months to November 11, 2026

TVRD news and analysis

RSS

No long-form analysis yet for TVRD. Pulse alerts and the live data picture are available on ORTEX.

Open TVRD on ORTEX →

Want the live picture for TVRD?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TVRD — free to start on ORTEX.

Sign up for free →Open TVRD on ORTEX